Taylor Wessing advised Cumulus Oncology Cumulus Oncology on its exclusive GPR68 licence and development collaboration with leadXpro. Cumulus Oncology and leadXpro initiated a groundbreaking collaboration in...
Cumulus Oncology and leadXpro’s Collaboration on GPR68-Targeting Cancer Therapeutics
Cumulus Oncology’s £9 Million Seed Funding Round
Burges Salmon advised cancer therapeutics company Cumulus Oncology Limited on the deal. Cumulus Oncology Limited completed a £9 million funding package secured from the Scottish National Investment Bank...